GGrantIndex
← Leaderboards

Carolyn J Anderson

Washington University

$12,609,741
Attributed
$15,566,296
Total exposure
17
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,566,296 · 17

By mechanism

R01$10,933,456 · 4
U01$1,244,365 · 1
R21$1,203,478 · 3
P30$1,016,220 · 2
K07$450,009 · 1
T90$353,214 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImagePositron-Emission TomographyCellsMolecular ImagingMalignant NeoplasmsFundingFutureBaseTreatment EfficacyMonitorNeoplastic CellTumorMolecularProgramsTracerResponseBiologyRadiotracerPathway InteractionsResearch PersonnelReceptorScientistReportingMediating

Grant awards (58)

PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$554,636
R01 · FY2025 · HL
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$694,482
R01 · FY2024 · HL
2024 Metals in Medicine Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2024 · EB · contact PI
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$666,750
R01 · FY2023 · HL
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$763,136
R01 · FY2022 · HL
World Molecular Imaging Congress. The WMIC provides a platform for a wide array of scientists and clinicians with diverse areas of expertise to interact, present, and discuss cutting-edge advances in$13,800
R13 · FY2022 · EB · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$432,877
R01 · FY2021 · CA · contact PI
World Molecular Imaging Congress 2021$11,500
R13 · FY2021 · EB · contact PI
In Vivo Imaging Facility$248,336
P30 · FY2020 · CA · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$247,713
R01 · FY2020 · CA · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$220,075
R01 · FY2020 · CA · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$458,957
R01 · FY2019 · CA · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$692,236
R01 · FY2018 · AI · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$481,065
R01 · FY2018 · CA · contact PI
In Vivo Imaging Facility$188,556
P30 · FY2018 · CA · contact PI
In Vivo Imaging Facility$8,613
P30 · FY2018 · CA · contact PI
In Vivo Imaging Facility$3,972
P30 · FY2018 · CA · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$707,272
R01 · FY2017 · AI · contact PI
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma$456,361
R01 · FY2017 · CA · contact PI
In Vivo Imaging Facility$188,556
P30 · FY2017 · CA · contact PI
Multimodal (PET/MR/NIR) imaging supported drug delivery in inflammatory diseases$181,450
R21 · FY2017 · EB · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$685,055
R01 · FY2016 · AI · contact PI
Multimodal (PET/MR/NIR) imaging supported drug delivery in inflammatory diseases$228,000
R21 · FY2016 · EB · contact PI
In Vivo Imaging Facility$189,488
P30 · FY2016 · CA · contact PI
PET Probes Targeting Immune Cells for Imaging Tuberculosis$740,094
R01 · FY2015 · AI · contact PI
In Vivo Imaging Facility$188,699
P30 · FY2015 · CA · contact PI
Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4$162,452
R21 · FY2014 · CA · contact PI
Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4$49,900
R21 · FY2014 · CA · contact PI
Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4$199,176
R21 · FY2013 · CA · contact PI
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY$327,244
R01 · FY2012 · CA · contact PI
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY$315,154
R01 · FY2011 · CA · contact PI
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY$292,410
R01 · FY2010 · CA · contact PI
RECEPTOR-TARGETED COPPER RADIOPHARMACEUTICALS FOR CANCER IMAGING AND THERAPY$292,410
R01 · FY2009 · CA · contact PI
SKILLS DEVELOPMENT COMPONENT$246,515
U01 · FY2009 · HL · contact PI
21st-Century Imaging Sciences: Undergraduate and Graduate Student Training$177,015
T90 · FY2009 · DA · contact PI
Training in Nanomedicine$106,783
U54 · FY2009 · CA · contact PI
21st-Century Imaging Sciences: Undergraduate and Graduate Student Training$73,739
R90 · FY2009 · DA · contact PI
SKILLS DEVELOPMENT COMPONENT$237,239
U01 · FY2008 · HL · contact PI
21st-Century Imaging Sciences: Undergraduate and Graduate Student Training$176,199
T90 · FY2008 · DA · contact PI
Curriculum for Imaging Sciences at Washington University (RMI)$92,089
K07 · FY2008 · GM · contact PI
21st-Century Imaging Sciences: Undergraduate and Graduate Student Training$77,045
R90 · FY2008 · DA · contact PI
Training in Nanomedicine$72,687
U54 · FY2008 · CA · contact PI
SKILLS DEVELOPMENT COMPONENT$220,761
U01 · FY2007 · HL · contact PI
Curriculum for Imaging Sciences at Washington University (RMI)$91,009
K07 · FY2007 · GM · contact PI
SKILLS DEVELOPMENT COMPONENT$336,533
U01 · FY2006 · HL · contact PI
Labeling of Octreotide with Positron Emitters$280,880
R01 · FY2006 · CA · contact PI
Curriculum:Imaging Sciences at Washington Universit(RMI)$89,969
K07 · FY2006 · GM · contact PI
Labeling of Octreotide with Positron Emitters$287,640
R01 · FY2005 · CA
SKILLS DEVELOPMENT COMPONENT$203,317
U01 · FY2005 · HL
Curriculum:Imaging Sciences at Washington Universit(RMI)$90,040
K07 · FY2005 · GM
Labeling of Octreotide with Positron Emitters$287,640
R01 · FY2004 · CA
Targeting Matrix Metalloproteinases for Tumor Imaging$191,250
R21 · FY2004 · CA
Curriculum:Imaging Sciences Washington University(RMI)$86,902
K07 · FY2004 · GM
Labeling of Octreotide with Positron Emitters$287,640
R01 · FY2003 · CA
Targeting Matrix Metalloproteinases for Tumor Imaging$191,250
R21 · FY2003 · CA
LABELING OF OCTREOTIDE WITH POSITRON EMITTERS$261,451
R01 · FY2002 · CA
LABELING OF OCTREOTIDE WITH POSITRON EMITTERS$253,835
R01 · FY2001 · CA
LABELING OF OCTREOTIDE WITH POSITRON EMITTERS$246,443
R01 · FY2000 · CA